Brief: Erytech Pharma Says Akkadian Has Initiated Proceedings To Postpone Vote On Merger With Pherecydes
June 5 (Reuters) - Erytech Pharma ERYP.PA :
* ERYTECH ANNOUNCES THAT AKKADIAN HAS INITIATED PROCEEDINGS
TO
POSTPONE THE VOTE ON THE MERGER WITH PHERECYDES
* AKKADIAN IS ALSO REQUESTING APPOINTMENT OF A LEGAL EXPERT
TO
REVIEW TERMS OF MERGER
* INTENDS TO OBTAIN DISMISSAL OF THIS LEGAL ACTION, WHICH IT
CONSIDERS UNFOUNDED, AND THUS ENABLE ITS SHAREHOLDERS TO VOTE ON
MERGER WITH PHERECYDES ON JUNE 23
Source text for Eikon: ID:nGNE7TzfKY
Further company coverage: ALPHE.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Phaxiam Therapeutics SA
See all newsBrief: Phaxiam Therapeutics Announces The Suspension Of Trading In Its Shares Until Delisting
Brief: Phaxiam Therapeutics Announces Judicial Liquidation And Delisting
Brief: Phaxiam Therapeutics Says Postponement Of The Offer Review Hearing
Brief: Phaxiam Therapeutics Announces Launch Of Process To Find Buyers In Context Of Its Receivership Procedure
Brief: Phaxiam Therapeutics Says Commercial Court Of Lyon To Open Judicial Receivership Procedure